Delivery Order SPE2DB22D3016-SPE2DB25FBHD4
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Loperamide 2 mg capsules (100 count) with a ceiling value of $1,067.84. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by August 20, 2025, with performance occurring at the vendor's Conshohocken location. The award is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,382.15 for 500 capsules of Loperamide 2 mg on September 11, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by September 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value pharmaceutical transaction issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,803.00 to AmerisourceBergen Drug Corp for the supply of 500 capsules of Loperamide 2 mg, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg with a ceiling value of $1,299.86 on August 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is not designated as a set-aside contract and was competitively awarded through open competition. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,290.32 for the supply of Loperamide HCL 500mg capsules on August 15, 2025. This firm fixed-price contract, which is not set-aside and competitively awarded, is scheduled for completion by August 18, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency component, with the place of performance at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, valued at $1,074.23, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Loperamide 2 mg capsules in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,063.67 and an ultimate completion date of September 5, 2025. The contract represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Loperamide 2 mg capsules in quantities of 500 units. This firm fixed-price delivery order, valued at $1,759.50, represents a non-set-aside competitive award with an ultimate completion date of August 27, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Loperamide Hydrochloride, an anti-diarrheal pharmaceutical. This competitively awarded, firm fixed-price delivery order has a ceiling value of $31.7K and an ultimate completion date of October 10, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 500 capsules of Loperamide 2 mg at a ceiling value of $1,234.15. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is set to be completed by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHD4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,322.07 for 500 capsules of Loperamide 2 mg on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. This $999,999,999.00 prime contract vehicle, which runs through December 2026, serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, functions as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, from generic medications to specialty drugs and medical supplies. This delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles that enable rapid fulfillment of pharmaceutical needs for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/4/25 |